International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 135-139 doi: 10.5281/zenodo.16434423
Original Article
Volume of Spontaneous Intracerebral Hemorrhage and Initial Glasgow Coma Scale as Predictors of 30-Day Mortality and Morbidity
 ,
 ,
 ,
 ,
 ,
 ,
Published
July 26, 2025
Abstract

Background: Spontaneous intracerebral hemorrhage (SICH) is a significant cause of stroke, with high mortality and morbidity rates. This study evaluates the influence of hematoma volume, anatomical location, and initial Glasgow Coma Scale (GCS) score on 30-day outcomes in SICH patients.

Methods: A prospective single-center study was conducted at Government Vellore Medical College Hospital, including 50 patients aged over 18 years with SICH confirmed by non-contrast CT brain imaging. Exclusion criteria included traumatic hemorrhage, subarachnoid hemorrhage, and secondary hemorrhages due to tumors or vascular malformations. Variables analyzed included demographic data, clinical features, GCS on admission, radiological findings, and in-hospital outcomes. Hematoma volume, anatomical location, and treatment modalities were correlated with mortality and morbidity.

Results: Of the 50 patients, 42% died within 30 days. Infratentorial hemorrhages were associated with the highest mortality (53.8%, p=0.04). Mean hematoma volume was 12.25 mL (SD 14.53) in deceased patients and 18.9 mL (SD 12.14) in survivors (p=0.38). Patients with intraventricular hemorrhage (IVH) had a 68.8% mortality rate. Surgical intervention (decompressive craniectomy or external ventricular drain) was performed in 86% of cases, with 51.2% survival.

Conclusion: Infratentorial location and IVH were significant predictors of poor outcome, while hematoma volume showed no statistically significant correlation with mortality.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1273 Views
3 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved